Japan’s regulatory agency is employing a holistic scientific method to get new pharmaceuticals and medical devices on the market in record time, while also minimizing risk. Dr. Tatsuya Kondo, the agency’s chief executive, explains how the approach could benefit the world and the need for global collaboration in the industryRead More
Osamu Nagayama, chairman of both Chugai Pharmaceutical and Sony, is one of Japan’s most visionary business leaders. Here, he explains how he carved out a unique way for Chugai to become a bigger player on the global stageRead More
Japan’s use of generic drugs has tripled in the last ten years. Not only is this saving the country billions of dollars, now Japanese generic drug manufacturers are investing more than ever in developing new, potentially life-saving techniques to make drugs easier to take, more convenient and more durableRead More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.